Sio Gene Therapies Dividends and Buybacks
Dividend criteria checks 0/6
Sio Gene Therapies does not have a record of paying a dividend.
Key information
n/a
Dividend yield
0%
Buyback Yield
| Total Shareholder Yield | 0% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Can Sio Gene Therapies (NASDAQ:SIOX) Afford To Invest In Growth?
Oct 19
Here's Why We're A Bit Worried About Sio Gene Therapies' (NASDAQ:SIOX) Cash Burn Situation
Jun 27My Favorite Stock For 2022: Sio Gene Therapies
Dec 27Sio Gene Therapies: Excellent Data And News Obscured By Officer's Departure
Oct 25We're Hopeful That Sio Gene Therapies (NASDAQ:SIOX) Will Use Its Cash Wisely
Sep 28Sio Gene Therapies EPS beats by $0.12
Jun 09Sio Gene Therapies: Gene Therapies For Neurodegeneration
May 28We Think Sio Gene Therapies (NASDAQ:SIOX) Needs To Drive Business Growth Carefully
May 07Have Insiders Been Buying Sio Gene Therapies, Inc. (NASDAQ:SIOX) Shares?
Mar 04Sio Gene Therapies secures $11.6M from sale of Arvelle Therapeutics
Feb 04What Is The Ownership Structure Like For Sio Gene Therapies, Inc. (NASDAQ:SIOX)?
Jan 28Sio Gene Therapies to sell Arvelle stake to Angelini Pharma
Jan 04Here's Why We're Watching Sio Gene Therapies' (NASDAQ:SIOX) Cash Burn Situation
Dec 24Sio Gene Therapies soars 45% on positive AXO-AAV-GM1 data in nerve cell disorder
Dec 16Did Sio Gene Therapies, Inc. (NASDAQ:SIOX) Insiders Buy Up More Shares?
Nov 19Axovant on go with pivotal study of gene therapy for rare inherited lipid disorders
Nov 09Axovant sees delayed enrollment in Parkinson’s study with gene therapy
Oct 29Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if SIOX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SIOX's dividend payments have been increasing.
Dividend Yield vs Market
| Sio Gene Therapies Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (SIOX) | n/a |
| Market Bottom 25% (US) | 1.3% |
| Market Top 25% (US) | 4.2% |
| Industry Average (Biotechs) | 2.3% |
| Analyst forecast (SIOX) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate SIOX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SIOX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate SIOX's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as SIOX has not reported any payouts.